| Patents for C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294) |
|---|
| 06/10/2008 | CA2369070C 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/04/2008 | EP1926720A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 06/04/2008 | CN100391963C Methods of producing C-aryl glucoside SGLT2 inhibitors |
| 05/28/2008 | EP1924571A2 Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 05/28/2008 | EP1585529A4 Process for the production of 2'-branched nucleosides |
| 05/28/2008 | CN100390190C Method of obtaining D-glucuronic acid |
| 05/28/2008 | CN100390189C Production of 2'-deoxynucleosides and 2'-deoxynucleoside precursors from 2-dehydro-3-deoxy-d-gluconate |
| 05/27/2008 | US7378519 enantiomerically pure 1S,2S-tramadol hydrochloride by dissolving topiramate and tramadol hydrochloride; cooling; crystallization; filtration; separating the 1S,2S-tramadol hydrochloride from the mother liquor by chromatography or crystallization |
| 05/27/2008 | US7378518 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 05/22/2008 | US20080119556 Geranly compounds |
| 05/20/2008 | US7375213 inhibitors of sodium dependent glucose transporters found in the intestine and kidney (SGLT2), and more particularly to a process of producing such compounds, for example dapagliflozin |
| 05/15/2008 | WO2008055870A1 Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 05/15/2008 | US20080113939 N-geranylgalacturonamide; anticarcinogenic, antitumor agent |
| 05/15/2008 | DE102006053637A1 Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted with fluorine 1,4-benzothiepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | DE102006053635A1 Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted benzyl 1,4-benzothiepine-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | CA2668623A1 Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 05/08/2008 | WO2007137258A3 C-glycolipids with enhanced th-1 profile |
| 05/06/2008 | US7368563 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, alzheimer's, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368562 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 05/02/2008 | WO2008049923A1 CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 05/02/2008 | CA2667550A1 Crystalline form of 4-(.beta.-d-glucopyranos-1-yl)-1-methyl-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/24/2008 | WO2008047779A1 Therapeutic or prophylactic agent for atopic dermatitis |
| 04/24/2008 | WO2008046155A1 Methods for regulating glucose homeostasis and agents therefor |
| 04/23/2008 | CN100383153C Method for decoloring digest of poly sialic acid |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 03/27/2008 | WO2008034990A1 Method for preparing a composition of glucuronic acid or a glucuronic-acid derivative comprising an electrochemical oxidation step |
| 03/27/2008 | WO2008034859A1 Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 03/27/2008 | WO2007038829A8 Method of drug design |
| 03/27/2008 | CA2664095A1 Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 03/13/2008 | WO2007128899A3 Stable c-glycoside sugar and c-glycoconjugate mimetics, method for preparing same and uses thereof in particular in cosmetics and drugs |
| 03/05/2008 | EP1893222A2 Anti-hypercholesterolemic compounds |
| 03/05/2008 | CN101134741A Catalyst for selective oxidation of protection monosaccharide primary hydroxy group |
| 02/21/2008 | WO2008020011A1 Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture |
| 02/21/2008 | WO2008019468A1 Process for obtaining an organic salt or organic acid from an aqueous sugar stream |
| 02/21/2008 | CA2661531A1 Method of obtaining an organic salt or acid from an aqueous sugar stream |
| 02/21/2008 | CA2656847A1 Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture |
| 02/20/2008 | EP1597266A4 A non-cryogenic process for forming glycosides |
| 02/20/2008 | EP1500660A4 Method for producing d-glucuronic acid |
| 02/20/2008 | CN101125837A C-glycosides type slycolipid compounds and use thereof |
| 02/20/2008 | CN100369925C Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 02/13/2008 | EP1885734A2 Immunogens for meningitidis-a vaccines |
| 02/13/2008 | EP1885694A2 4-biarylyl-1-phenylazetidin-2-ones |
| 01/31/2008 | WO2008013321A1 Novel sglt inhibitors |
| 01/23/2008 | EP1879860A2 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 01/16/2008 | EP1877373A2 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/09/2008 | EP1874787A1 Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors |
| 01/09/2008 | EP1765842B1 D-xylopyranosyl-substituted phenyls, medicaments containing said compounds, the use thereof, and methods for producing the same |
| 01/03/2008 | WO2008002824A1 Crystalline solvates and complexes of (is) -1, 5-anhydro-l-c- (3- ( (phenyl) methyl) phenyl) -d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes |
| 01/03/2008 | CA2653344A1 Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl)methyl)phenyl-d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes |
| 01/02/2008 | CN101096377A Monoglycosides acid purification method |
| 12/26/2007 | CN101092409A C-aryl glucoside sglt2 inhibitors and method |
| 12/19/2007 | EP1866323A2 Glucuronidated nebivolol |
| 12/19/2007 | CN100355766C Method for preparing and purifying uperarin through membrane technology |
| 12/05/2007 | EP1330465B1 Derivatised carbohydrates and their use in solid delivery systems |
| 11/29/2007 | CA2653647A1 C-glycolipids with enhanced th-1 profile |
| 11/22/2007 | US20070270375 Obtained from plants of Barringtonia species which are derived from Barringtoside A and Barringtoside C as precursor compounds which especially have an arabinopyranosyl substituent at 21 position, which may optionally be further substituted with benzoyl, dibenzoyl, methyl butanoyl, at 3 or 4 position |
| 11/22/2007 | US20070270354 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 11/21/2007 | EP1003366B1 Methods for producing sialyloligosaccharides in a dairy source |
| 11/19/2007 | CA2588882A1 Flavonoid sugar addition products, method for manufacture and use thereof |
| 11/15/2007 | CA2650942A1 Stable c-glycoside sugar and c-glycoconjugate mimetics, method for preparing same and uses thereof in particular in cosmetics and drugs |
| 11/08/2007 | WO2007125203A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials. |
| 11/08/2007 | WO2007125194A1 New gem-difluoro c-glycoside compounds derived from podophyllotoxin, preparation and uses thereof |
| 11/08/2007 | CA2650384A1 Novel gem-difluorinated c-glycoside compounds derived from podophyllotoxin, their preparation and their applications |
| 11/08/2007 | CA2649993A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials. |
| 11/06/2007 | US7291463 Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis |
| 10/31/2007 | EP1848418A2 Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection |
| 10/31/2007 | CN101065391A C-aryl glucoside sglt2 inhibitors and method |
| 10/18/2007 | WO2007116013A1 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 10/17/2007 | CN100343264C Process for producing sugar chain asparagine derivative |
| 10/16/2007 | US7282485 Heating salts of 1,2-O-isopropylidene-D-glucuronic acid in water-containing solution in presence of an acid agent (sulphonic acid cation exchanger resins) |
| 10/11/2007 | US20070238866 Methods of producing c-aryl glucoside sglt2 inhibitors |
| 09/27/2007 | WO2007109813A1 Imidazoquinoxaline compounds as immunomodulators |
| 09/27/2007 | CA2646539A1 Imidazoquinoxaline compounds as immunomodulators |
| 09/26/2007 | CN101041660A 1,2-dihydrogen pyridine derivative, carbon glycosides intermediate and preparation method and application thereof |
| 09/25/2007 | US7273852 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases |
| 09/20/2007 | WO2007105094A1 Method for the identification of new leads for drug candidates |
| 09/19/2007 | CN100338085C Sialic carbohydrates |
| 09/18/2007 | CA2415097C Process and intermediate compounds for the preparation of pyrrolidines |
| 09/13/2007 | US20070212759 Production Of 2'-Deoxynucleosides And 2'-Deoxynucleoside Precursors From 2-Dehydro-3-Deoxy-D-Gluconate |
| 09/05/2007 | EP1828216A2 Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 08/29/2007 | EP1412368B1 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain |
| 08/14/2007 | CA2334656C Method for preparing aloin by extraction |
| 08/08/2007 | EP0927180B1 Heterocyclic compounds and their use for isolating nucleic acids |
| 07/12/2007 | WO2006120576A3 Immunogens for meningitidis-a vaccines |
| 07/12/2007 | DE19981703B4 Verfahren zur Erhöhung der Reinheit der racemischen Form von Metallocenkomplexen A process for increasing the purity of the racemic form of metallocene |
| 07/04/2007 | EP1803721A1 Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 07/04/2007 | CN1990479A 3-alkoxy substituted-2, 5, 7-tri-substituted benzopyran-4-ketones compounds, preparing method thereof and pharmaceutical compounds containing same |
| 06/28/2007 | US20070148744 inhibitors of vacuolar-type H+-ATPase; antibiotic; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16- [(1S,2R,3S)-3-[(2R,4R,5S,6R)-2,4-dihydroxy-6- isopropyl-5-methyl-2-tetrahydropyranyl]-2- hydroxy-1-methylbutyl]-8-hydroxy-3,15- dimethoxy-5,7,9,11-tetramethyl-1- oxacyclohexadeca-3,5,11,13-tetraen-2-one |
| 06/26/2007 | US7235543 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 06/20/2007 | EP1797107A2 D-pyranosyl-substituted phenyls, medicaments containing said compounds, use thereof, and method for the production thereof |
| 06/20/2007 | CN1984898A Process for production of azulene derivatives and intermediates for the synthesis of the same |
| 06/14/2007 | US20070134646 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 06/06/2007 | EP1791852A2 C-aryl glucoside sglt2 inhibitors and method for their production |
| 05/31/2007 | US20070123717 Method for the production of 2-keto-l-gulonic acid esters |
| 05/29/2007 | CA2168080C Process for the preparation of 1-(2'-deoxy-2',2'-difluoro- d-ribopentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro- beta-d-ribo-pentopyranose |
| 05/22/2007 | US7220731 Trisaccharide or higher polysaccharide; systems useful for dissolution, encapsulation, storage and delivery of therapeutic and diagnostic molecules |
| 05/22/2007 | CA2212200C Novel inhibitors of .beta.-glucuronidase |